The DNA damage response: implications for tumor responses to radiation and chemotherapy
- PMID: 25423595
- DOI: 10.1146/annurev-med-081313-121208
The DNA damage response: implications for tumor responses to radiation and chemotherapy
Abstract
Cellular responses to DNA damage are important determinants of both cancer development and cancer outcome following radiation therapy and chemotherapy. Identification of molecular pathways governing DNA damage signaling and DNA repair in response to different types of DNA lesions allows for a better understanding of the effects of radiation and chemotherapy on normal and tumor cells. Although dysregulation of the DNA damage response (DDR) is associated with predisposition to cancer development, it can also result in hypersensitivity or resistance of tumors to therapy and can be exploited for improvement of cancer treatment. We highlight the DDR pathways that are activated after treatment with radiation and different classes of chemotherapeutic drugs and describe mechanisms determining tumor sensitivity and resistance to these agents. Further, we discuss approaches to enhance tumor sensitivity to radiation and chemotherapy by modulating the DDR with a goal of enhancing the effectiveness of cancer therapies.
Keywords: DNA repair; cancer resistance; chemosensitization; radiosensitization; synthetic lethality.
Similar articles
-
Understanding DNA damage response and DNA repair pathways: applications to more targeted cancer therapeutics.Semin Oncol. 2009 Apr;36(2 Suppl 1):S42-51. doi: 10.1053/j.seminoncol.2009.02.004. Semin Oncol. 2009. PMID: 19393835
-
MicroRNAs, DNA Damage Response, and Cancer Treatment.Int J Mol Sci. 2016 Dec 12;17(12):2087. doi: 10.3390/ijms17122087. Int J Mol Sci. 2016. PMID: 27973455 Free PMC article. Review.
-
Targeting the microRNA-regulating DNA damage/repair pathways in cancer.Expert Opin Biol Ther. 2014 Nov;14(11):1667-83. doi: 10.1517/14712598.2014.950650. Epub 2014 Sep 5. Expert Opin Biol Ther. 2014. PMID: 25190496 Review.
-
DNA damage response--a double-edged sword in cancer prevention and cancer therapy.Cancer Lett. 2015 Mar 1;358(1):8-16. doi: 10.1016/j.canlet.2014.12.038. Epub 2014 Dec 17. Cancer Lett. 2015. PMID: 25528631 Review.
-
Targeting the DNA Damage Response in Cancer.Mol Cell. 2015 Nov 19;60(4):547-60. doi: 10.1016/j.molcel.2015.10.040. Mol Cell. 2015. PMID: 26590714 Review.
Cited by
-
Neutrophil-related genes predict prognosis and response to immune checkpoint inhibitors in bladder cancer.Front Pharmacol. 2022 Oct 21;13:1013672. doi: 10.3389/fphar.2022.1013672. eCollection 2022. Front Pharmacol. 2022. PMID: 36339597 Free PMC article.
-
CDK4/6 inhibitors: a novel strategy for tumor radiosensitization.J Exp Clin Cancer Res. 2020 Sep 15;39(1):188. doi: 10.1186/s13046-020-01693-w. J Exp Clin Cancer Res. 2020. PMID: 32933570 Free PMC article. Review.
-
Kinetochore protein MAD1 participates in the DNA damage response through ataxia-telangiectasia mutated kinase-mediated phosphorylation and enhanced interaction with KU80.Cancer Biol Med. 2020 Aug 15;17(3):640-651. doi: 10.20892/j.issn.2095-3941.2020.0044. Cancer Biol Med. 2020. PMID: 32944396 Free PMC article.
-
Finding an easy way to harmonize: a review of advances in clinical research and combination strategies of EZH2 inhibitors.Clin Epigenetics. 2021 Mar 24;13(1):62. doi: 10.1186/s13148-021-01045-1. Clin Epigenetics. 2021. PMID: 33761979 Free PMC article. Review.
-
MicroRNAs as Epigenetic Determinants of Treatment Response and Potential Therapeutic Targets in Prostate Cancer.Cancers (Basel). 2021 May 14;13(10):2380. doi: 10.3390/cancers13102380. Cancers (Basel). 2021. PMID: 34069147 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
